Literature DB >> 2321992

Anatomic distribution of acquired melanocytic nevi in white children. A comparison with melanoma: the Vancouver Mole Study.

R P Gallagher1, D I McLean, C P Yang, A J Coldman, H K Silver, J J Spinelli, M Beagrie.   

Abstract

The presence of acquired benign nevi is a risk factor for cutaneous melanoma, yet relatively little is known about the etiology of nevi. We have conducted a study of the prevalence of melanocytic nevi among 1146 white Vancouver (Canada) schoolchildren aged 6 to 18 years. Numbers of nevi per square meter of body surface area increase with age in children of both sexes. Male adolescents have more nevi than female adolescents on the head and neck as well as on the trunk, while prevalence in females is higher on the upper and lower limbs. This distribution parallels that of cutaneous melanoma in British Columbia adults. Nevi are more common in children on intermittently exposed body sites than on constantly or minimally sun-exposed sites. This suggests that exposure to strong intermittent sunlight in childhood (a risk factor for cutaneous melanoma) may also be important in the etiology of acquired benign nevi.

Entities:  

Mesh:

Year:  1990        PMID: 2321992

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  15 in total

Review 1.  The detection and management of dysplastic nevi and early melanoma.

Authors:  J K Rivers
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

Review 2.  The study of nevi in children: Principles learned and implications for melanoma diagnosis.

Authors:  Alon Scope; Michael A Marchetti; Ashfaq A Marghoob; Stephen W Dusza; Alan C Geller; Jaya M Satagopan; Martin A Weinstock; Marianne Berwick; Allan C Halpern
Journal:  J Am Acad Dermatol       Date:  2016-06-17       Impact factor: 11.527

3.  Effect of hair color and sun sensitivity on nevus counts in white children in Colorado.

Authors:  Jenny Aalborg; Joseph G Morelli; Tim E Byers; Stefan T Mokrohisky; Lori A Crane
Journal:  J Am Acad Dermatol       Date:  2010-06-26       Impact factor: 11.527

4.  Sunburn, sun exposure, and sun sensitivity in the Study of Nevi in Children.

Authors:  Jaya M Satagopan; Susan A Oliveria; Arshi Arora; Michael A Marchetti; Irene Orlow; Stephen W Dusza; Martin A Weinstock; Alon Scope; Alan C Geller; Ashfaq A Marghoob; Allan C Halpern
Journal:  Ann Epidemiol       Date:  2015-05-23       Impact factor: 3.797

Review 5.  Melanoma risk factors and atypical moles.

Authors:  M L Williams; R W Sagebiel
Journal:  West J Med       Date:  1994-04

6.  Melanocytic nevus development in Colorado children born in 1998: a longitudinal study.

Authors:  Lori A Crane; Stefan T Mokrohisky; Robert P Dellavalle; Nancy L Asdigian; Jenny Aalborg; Tim E Byers; Chan Zeng; Anna E Barón; Joanna M Burch; Joseph G Morelli
Journal:  Arch Dermatol       Date:  2009-02

7.  Assessment of elementary school students' sun protection behaviors.

Authors:  Seft Hunter; Kristen J Wells; Paul B Jacobsen; Ji-Hyun Lee; David Boulware; Kymia Love-Jackson; Rania Abdulla; Richard G Roetzheim
Journal:  Pediatr Dermatol       Date:  2009-07-20       Impact factor: 1.588

8.  The anatomic distribution of melanoma and relationships with childhood nevus distribution in Colorado.

Authors:  Ashley L Juhl; Tim E Byers; William A Robinson; Joseph G Morelli; Lori A Crane
Journal:  Melanoma Res       Date:  2009-08       Impact factor: 3.599

9.  Melanocytic nevi and sun exposure in a cohort of colorado children: anatomic distribution and site-specific sunburn.

Authors:  Athena T Dodd; Joseph Morelli; Stefan T Mokrohisky; Nancy Asdigian; Tim E Byers; Lori A Crane
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-10       Impact factor: 4.254

10.  Trajectories of Nevus Development From Age 3 to 16 Years in the Colorado Kids Sun Care Program Cohort.

Authors:  Nancy L Asdigian; Anna E Barón; Joseph G Morelli; Stefan T Mokrohisky; Jenny Aalborg; Robert P Dellavalle; Matthew F Daley; Marianne Berwick; Keith E Muller; Neil F Box; Lori A Crane
Journal:  JAMA Dermatol       Date:  2018-11-01       Impact factor: 10.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.